Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I and pharmacokinetic study of a daily times 5 short intravenous infusion schedule of 9-aminocamptothecin in a colloidal dispersion formulation in patients with advanced solid tumors.
Herben VM, van Gijn R, Schellens JH, Schot M, Lieverst J, Hillebrand MJ, Schoemaker NE, Porro MG, Beijnen JH, ten Bokkel Huinink WW. Herben VM, et al. Among authors: van gijn r. J Clin Oncol. 1999 Jun;17(6):1906-14. doi: 10.1200/JCO.1999.17.6.1906. J Clin Oncol. 1999. PMID: 10561232 Clinical Trial.
Analytical procedure for the determination of the new antitumour drug N-benzoylstaurosporine and three potential metabolites in human plasma by reversed-phase high-performance liquid chromatography.
van Gijn R, van Tellingen O, de Clippeleir JJ, Hillebrand MJ, Boven E, Vermorken JB, ten Bokkel Huinink WW, Schwertz S, Graf P, Beijnen JH. van Gijn R, et al. Among authors: van tellingen o. J Chromatogr B Biomed Appl. 1995 May 19;667(2):269-76. doi: 10.1016/0378-4347(95)00037-j. J Chromatogr B Biomed Appl. 1995. PMID: 7663699
Determination of intoplicine, a new antitumour drug, in human whole blood and plasma by normal-phase high-performance liquid chromatography with fluorescence detection.
van Gijn R, Rosing H, ten Bokkel Huinink WW, van Tellingen O, Vermorken JB, Liefting AJ, Bruno R, Pinedo HM, Beijnen JH. van Gijn R, et al. Among authors: van tellingen o. J Chromatogr. 1993 May 5;614(2):299-306. doi: 10.1016/0378-4347(93)80322-u. J Chromatogr. 1993. PMID: 8314943 Clinical Trial.
Comparative open, randomized, cross-over bioequivalence study of two intravenous dexrazoxane formulations (Cardioxane and ICRF-187) in patients with advanced breast cancer, treated with 5-fluorouracil-doxorubicin-cyclophosphamide (FDC).
Rosing H, ten Bokkel Huinink WW, van Gijn R, Rombouts RF, Bult A, Beijnen JH. Rosing H, et al. Among authors: van gijn r. Eur J Drug Metab Pharmacokinet. 1999 Jan-Mar;24(1):69-77. doi: 10.1007/BF03190013. Eur J Drug Metab Pharmacokinet. 1999. PMID: 10412894 Clinical Trial.
26 results